Twitter, Inc. (TWTR) was downgraded by Evercore ISI to a ‘Hold’ from ‘Buy’ rating in a research note issued on Thursday. The firm cut the company’s price target to $39 from $49 saying TWTR is on a “competitive convergence” with Facebook (FB), and that the latter is pulling ahead. Evercore’s new PT implies 25% expected downside.
TWTR shares recently lost $0.40 to $36.60. In the past 52 weeks, shares of San Francisco, Calif.-based online social networking services have traded between a low of $33.09 and a high of $55.99. Shares are up 13.57% year-over-year and 3.15% year-to-date.
Analysts at Morgan Stanley (MS) downgraded GlaxoSmithKline plc (GSK) from ‘Overweight‘ to ‘Equal-Weight‘ in a research report issued to clients on Thursday.
On valuation measures, GlaxoSmithKline plc ADS stock it’s trading at a forward P/E multiple of 18.15x, and at a multiple of 6.55x this year’s estimated earnings. The t-12-month revenue at GlaxoSmithKline is $35.25 billion. GSK’s ROE for the same period is 107.76%.
Shares of the $104.21 billion market cap company are down 12.64% year-over-year ; up 5.89% year-to-date.
GlaxoSmithKline plc, currently with a median Wall Street price target of $47.00 and a high target of $55.25, dropped $0.88 to $43.15 in recent trading.
The chart below shows where the equity has traded over the past 52-weeks.
Verizon Communications Inc. (VZ) was downgraded from ‘Overweight‘ to ‘Neutral‘ at JP Morgan (JPM).
Shares have traded today between $47.91 and $48.54 with the price of the stock fluctuating between $45.09 to $53.66 over the last 52 weeks.
Verizon Communications Inc. shares are currently changing hands at 20.19x this year’s forecasted earnings, compared to the industry’s 23.08x earnings multiple. Ticker has a t-12 price/sales ratio of 1.56. EPS for the same period registers at $2.38.
Shares of Verizon have lost $1.01 to $48.07 in midday trading on Thursday, giving it a market cap of roughly $196 billion. The stock traded as high as $53.66 in July 29, 2014.